The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
kang zhong liu yao wu de fu mo nei gei yao
Author(s): 
Pages: 111-113
Year: Issue:  2
Journal: Foreign Medical Sciences(Section of Pharmarcy)

Keyword:  顺铂卡铂紫杉醇腹膜给药抗肿瘤药物;
Abstract: 腹膜内直接给予抗肿瘤药物治疗癌症 ,其药代动力学优于目前抗肿瘤药物的全身给药。临床前和临床试验资料表明 ,腹膜内给药可增加肿瘤部位的抗肿瘤药物浓度 ,并延长药物作用时间。Ⅰ /Ⅱ期的临床试验进一步证实了这一方法可提高癌症患者的生存率。该方法对于卵巢癌具有较好的疗效。尚需充分的Ⅲ期临床试验研究 ,以评价该法作为临床治疗标准方法的可行性
Related Articles
loading...